Gemtesa (vibegron): what it treats, how to take it, side effects
Last updated September 3, 2026.
Gemtesa (vibegron) is a once-daily beta-3 adrenergic agonist for overactive bladder, approved in 2020 as the modern alternative to anticholinergic bladder drugs. It relaxes the bladder's detrusor muscle during filling by a completely different route, which means no anticholinergic dry mouth, constipation, or brain fog, and in 2024 it gained an indication for overactive bladder in men with benign prostatic hyperplasia.
What does it treat?
Overactive bladder in adults: urgency, frequency, and urge urinary incontinence, including in men whose bladder symptoms coexist with BPH. Trials show fewer daily urgency episodes and leaks versus placebo, with a side-effect profile close to placebo, which is its selling point against the older class.
How do you take it?
One 75 mg tablet once daily, with or without food, at the same time each day. If swallowing is hard, the label allows crushing the tablet into a tablespoon of applesauce, taken immediately with water. Missed dose: take it when remembered unless the next dose is near; never double up. Improvement builds over the first weeks; judge it around week 12, the trial endpoint. It controls symptoms rather than curing them, so keep taking it even when the bathroom map fades from your life.
Side effects to know
- Common: urinary tract infections, headache, cold-like symptoms, nausea, and diarrhea; hypertension rates in trials tracked placebo closely.
- Serious: urinary retention (the risk is higher with bladder-outlet obstruction or when combined with anticholinergic bladder drugs, and retention means stopping), and rare angioedema, which the label added to warnings in 2024.
Who should not take it?
Anyone with a prior hypersensitivity to vibegron. Trouble emptying the bladder or a weak stream deserves a mention before starting, because retention risk concentrates there. Severe kidney or liver impairment is specialist territory. It raises digoxin levels measurably, so patients on digoxin get monitored. Pregnancy and breastfeeding data are thin; that is a clinician conversation.
When is it an emergency?
Call 911 for facial, lip, tongue, or throat swelling or trouble breathing (angioedema). Inability to urinate with a painfully full bladder needs emergency care. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
How is Gemtesa different from oxybutynin or Toviaz?
Mechanism. Those are anticholinergics, blocking the squeeze signal and bringing dry mouth, constipation, blurred vision, and brain fog along for the ride. Vibegron activates beta-3 receptors to relax the bladder during filling, a route with no anticholinergic effects at all, which is why its trial side-effect rates sat near placebo.
Does it raise blood pressure?
In the trials, hypertension rates on vibegron tracked placebo closely, unlike its older cousin mirabegron, which has a clearer blood-pressure signal. Routine home or clinic blood-pressure checks remain sensible, especially in the first months, but the data is reassuring.
Can men with prostate enlargement take it?
Yes, and that is now official: the label gained an indication for overactive bladder in men with BPH in late 2024, with trial data behind it. The retention caution still applies, since an obstructed outlet plus any bladder relaxant needs watching, but it is a watched yes, not a no.
Can I crush the tablet?
Yes, unusually for this kind of drug: crush it into a tablespoon of applesauce and swallow immediately with water. That flexibility matters for older patients and anyone with swallowing difficulty, and it is right in the labeling.
How long before I notice fewer bathroom trips?
Most trial patients saw meaningful change within the first 2 weeks, with the full measured effect at 12 weeks. It is not instant, but it is faster than the anticholinergic slog, and the improvements are in the counts that matter: fewer urgency episodes, fewer leaks, fewer night trips.
Can I take it with my other bladder pill?
Combining vibegron with an anticholinergic (mirabegron-plus-tolterodine style stacking) is done by urologists for refractory cases, but the label flags that the retention risk rises in that combination. It is a specialist move with monitoring, never a self-add.